Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 121Breast Neoplasms 83Colorectal Neoplasms 52Stomach Neoplasms 42Pancreatic Neoplasms 42Lung Neoplasms 41Rectal Neoplasms 38Neoplasm Metastasis 36Neoplasms 33Esophageal Squamous Cell Carcinoma 32Esophageal Neoplasms 31Head and Neck Neoplasms 26Squamous Cell Carcinoma of Head and Neck 23Ovarian Neoplasms 23Triple Negative Breast Neoplasms 21Nasopharyngeal Carcinoma 20Recurrence 18Leukemia, Myeloid, Acute 18Colonic Neoplasms 18Uterine Cervical Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Small Cell Lung Carcinoma 15Glioblastoma 15Lymphoma 12Prostatic Neoplasms 11Fallopian Tube Neoplasms 11Carcinoma, Squamous Cell 11Brain Neoplasms 11Sarcoma 10NSCLC 9

Interventions

Propofol 2Dexmedetomidine 2contrast agent BR1 1Therapeutics 1Sevoflurane 1Ropivacaine 1Nitrous Oxide 1Lidocaine 1Iohexol 1Glycopyrrolate 1Food, Formulated 1FS 069 1Embolization, Therapeutic 1Drug Therapy 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Abdominal Neoplasms × Drug Therapy × Clear all
NCT03966456 2019-05-29

Real World Study of Four PD-1 Agents in China

The Affiliated Hospital of Qingdao University

Unknown
500 enrolled
Dermatologic

Abdominal Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡